Christine N. Kay, MD, discussed her presentation, "Deuterated vitamin A preserves vision in Stargardt’s disease (TEASE study) ...

Thomas Aaberg, Jr, MD, Neurotech's Chief Medical Officer, shared some insights on the company's recent presentation as well ...

Yashdeep Das, MBBS, and colleagues evaluated the structures of the retina in patients with amblyopia and found what they described as significant structural differences. Das is from the All India ...

In the first five months of the program at Henrietta Johnson Medical Center, 26% of patients with images gradable by EyeArt tested positive for either more-than-mild or vision-threatening diabetic ...

Tinlarebant is an oral therapy designed to reduce the accumulation of vitamin A based toxins that cause retinal disease.

A recent study found that a history of posterior capsule rupture (PCR) in the first eye that underwent cataract surgery was an independent risk factor for the occurrence of the same complication in ...

R. Theodore Smith, MD, PhD, Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai, New York, reported that cardiac arrhythmias such as atrial fibrillation are associated with ...

The results of a new study has shown that photobiomodulation, a non-invasive treatment, may be another method for treating dry age-related macular degeneration (AMD). David S. Boyer, MD, of ...

PMC-403 is a novel TIE2-activating antibody with a mechanism that stabilizes pathological, leaky blood vessels. The TIE2-activating antibody candidate, PMC-403, by PharmAbcine has received unanimous ...

A recently approved artificial intelligence home-based optical coherence tomography (OCT) device from Notal Vision Inc. allows patients with age-related macular degeneration (AMD) to test themselves ...

Ferhina S. Ali, MD, MPH, discusses how to effectively manage geographic atrophy by considering treatment timing, utilizing imaging modalities, analyzing phase 3 trial data, and developing personalized ...